Navigation Links
Cardium Reports on Applicability of Corgentin to Stem Cell Therapies: Independent Studies Indicate that Ad5IGF-1 Potentiates Stem Cells to Improve Cardiac Function After Heart Attack
Date:3/27/2009

terially from stated expectations. For example, there can be no assurance that results or trends observed in pre-clinical studies will be reproduced in subsequent studies, that human clinical trials can be conducted and completed in an efficient and successful manner, that product modifications or launches will be successful or that the resulting products will be favorably received in the marketplace, that our products or proposed products will prove to be sufficiently safe and effective, that necessary regulatory approvals will be obtained, or that our products or product candidates will not be unfavorably compared to competitive products that may be regarded as safer, more effective, easier to use or less expensive. Actual results may also differ substantially from those described in or contemplated by this press release due to risks and uncertainties that exist in our operations and business environment, including, without limitation, risks and uncertainties that are inherent in the development of complex biologics and the conduct of human clinical trials, including the timing, costs and outcomes of such trials, and our ability to obtain necessary funding, regulatory approvals and expected qualifications, our limited experience in the development, testing and marketing of complex biologics and therapeutic hypothermia devices and whether our efforts to accelerate the commercialization of such products or proposed products will be successful or completed within the timeframes contemplated, our dependence upon proprietary technology, our history of operating losses and accumulated deficits, our reliance on collaborative relationships and critical personnel, and current and future competition, as well as other risks described from time to time in filings we make with the Securities and Exchange Commission. We undertake no obligation to release publicly the results of any revisions to these forward-looking statements to reflect events or circumstances arising after
'/>"/>
SOURCE Cardium Therapeutics
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6

Related medicine technology :

1. Cardiums InnerCool Announces Positive Benefits of Cooling During Robotic-Assisted Prostate Surgery Published in Urology
2. Cardium Reports on Second Quarter 2008 Highlights and Financial Results
3. Cardium Announces Appointment of Paul A. Foster, M.D. to Lead Generx and Excellarate Late-Stage Development Activities
4. Cardiums Innercool Therapies Unit Announces Publication of Positive Effects of Early and Rapid Hypothermia Following Heart Attack
5. Cardium and Tissue Repair Companys Excellarate Candidate for Healing Diabetic Wounds Gains Media Focus in Multiple Regions Across U.S.
6. Poniard Pharmaceuticals Reports Fourth Quarter and Year End 2008 Financial Results and Provides a Corporate Update
7. DURECT Reports Positive Phase IIb Data from TRANSDU(TM)-Sufentanil Clinical Program
8. ExonHit Reports Proof-of-Concept in Breast Cancer Diagnostic Using its SpliceArray(TM) Platform
9. Alimera Reports Favorable Safety and Efficacy Results From the 12-Month Interim Readout of the Human PK Iluvien(TM) Study
10. Terumo Heart, Inc. Reports Clinical Progress in the DuraHeart(TM) U.S. Pivotal Trial as NewYork-Presbyterian Hospital/Columbia University Medical Center Implants First Patient
11. Isolagen, Inc. Reports Positive Top-line Results from Phase II/III Study of Isolagen Therapy(TM) to Treat Moderate to Severe Acne Scars: Study Meets All Primary Efficacy Endpoints and is Statistically Significant
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:8/1/2014)... and NEW YORK , Aug. 1, ... Pershing Square Capital Management, L.P. today responded to the ... AGN ) in California.  The complaint makes ... tender offer rules.  Allergan,s true purpose ... with shareholders, efforts to call a special meeting.  That ...
(Date:8/1/2014)... 1, 2014  VanDeMark Chemical Inc., ... of phosgene and phosgene derivatives in ... has acquired Framochem Kft, a leading European-based manufacturer ... . The purchase unites two ... of the world,s largest, independent manufacturers of products ...
(Date:8/1/2014)... Aspire Technology Partners (Aspire) announced today that it has achieved ... recognizes Aspire for delivering outstanding customer service to customers in ... "Achieving exceptional results for our customers is core to ... CEO of Aspire. "We are pleased Cisco has recognized our ... are proud to be part of the Cisco channel." ...
Breaking Medicine Technology:Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 2Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 3Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 4Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 5Valeant Pharmaceuticals And Pershing Square Respond To Frivolous Allergan Lawsuit 6VanDeMark Chemical Inc. Acquires Framochem 2VanDeMark Chemical Inc. Acquires Framochem 3VanDeMark Chemical Inc. Acquires Framochem 4Aspire Technology Partners Recognized By Cisco For Excellence In Customer Satisfaction 2
(Date:8/1/2014)... News) -- Almost 140 people die every year ... United States. But there are several simple ... injury prevention coordinator at Cincinnati Children,s Hospital Medical ... medical center news release. "As families begin ... important for parents and children to go over ...
(Date:8/1/2014)... (PRWEB) August 01, 2014 As AndroGel ... the country, Ronald E. Johnson, Jr. has been appointed ... AndroGel and other testosterone medications. Since the Fall of ... P.S.C. have worked diligently to investigate and prosecute the ... embolisms, and blood clots as a result of taking ...
(Date:8/1/2014)... UK (PRWEB) August 01, 2014 ... Publications research reports have been added to its ... Formulations, Active Pharmaceutical Ingredients (APIs), Contract Research and ... The key pharma industry drivers include, among others, ... of personal hygiene. In 2015, the pharma market ...
(Date:8/1/2014)... Alan Mozes HealthDay Reporter ... country, barbershops serve as a time-honored destination for a good ... whether barbershops might also be the spot to tackle an ... In a novel partnership, the U.S. Centers for Disease ... Health (MSDH), enlisted the help of barbershop staff to both ...
(Date:8/1/2014)... NY (PRWEB) August 01, 2014 ... industry have benefited from innovative technologies that have ... resemble a patient's tooth color. Moreover, the burgeoning ... due to age-related tooth ailments. Due to long-term ... many elderly individuals have demanded dental fillings, veneers ...
Breaking Medicine News(10 mins):Health News:Expert Offers School Bus Safety Tips 2Health News:Ron Johnson Named Co-Lead Counsel in Lawsuits for Men Injured by AndroGel and Testosterone 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 2Health News:In-demand Markets Research Reports by Kelly Scientific Publications Now Available at MarketPublishers.com 3Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 2Health News:Barbershops Join Fight Against High Blood Pressure in Black Men 3Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 2Health News:Cosmetic Dentists in the US Industry Market Research Report from IBISWorld Has Been Updated 3
... , WEDNESDAY, April 13 (HealthDay News) -- A ... food, researchers report. It was already known that ghrelin ... the hormone may increase the ability to use smell to ... regulation of metabolism and body weight, said University of Cincinnati ...
... , TUESDAY, April 12 (HealthDay News) -- Many smokers ... cigarettes, such as "mild" and "low tar" brands, are less ... Researchers surveyed more than 8,000 smokers in Australia, Canada, ... about one-fifth of them wrongly believed that "some cigarettes could ...
... 12 (HealthDay News) -- Scientists are rearranging the genetic information ... way to learn more about the genetic causes in people ... of the immune system. Humans and dogs have a ... including lymphoma. In purebred dogs of the same breed, however, ...
... a laboratory model of idiopathic torsion dystonia, a neurological ... postures. But the genetic defect that causes dystonia in ... that showed no symptoms whatsoever. Now, a team ... have figured out why and the finding could lead ...
... HealthDay Reporter , TUESDAY, April 12 (HealthDay News) -- ... taking the arthritis drug Humira developed an immune system reaction ... finding helps to explain why some people get relief from ... made by Abbott Laboratories, while others gain little or no ...
... from heart attacks Angiogenesis, the development of ... wound healing, as well as during disease processes such ... incompletely understood, but could represent novel targets for the ... In this paper, Young-Guen Kwon and colleagues, of Yonsei ...
Cached Medicine News:Health News:Many Smokers Still Deceived by Cigarette Labeling 2Health News:Could Dogs' DNA Give Clues to Human Lymphoma? 2Health News:Feinstein scientists identify abnormal disease pathway in dystonia 2Health News:Clues to Why Rheumatoid Arthritis Drug Humira Fails Some Patients 2Health News:Clues to Why Rheumatoid Arthritis Drug Humira Fails Some Patients 3Health News:JCI online early table of contents: April 11, 2011 2Health News:JCI online early table of contents: April 11, 2011 3Health News:JCI online early table of contents: April 11, 2011 4Health News:JCI online early table of contents: April 11, 2011 5Health News:JCI online early table of contents: April 11, 2011 6Health News:JCI online early table of contents: April 11, 2011 7Health News:JCI online early table of contents: April 11, 2011 8
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
... ARUP Laboratories is a national reference ... laboratory research and development. ARUP offers an ... unique medical tests in clinical and anatomic ... ARUP Laboratories' clients include more than half ...
... national reference laboratory and a worldwide leader ... offers an extensive test menu of highly ... and anatomic pathology. Owned by the University ... than half of the nation's university teaching ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: